These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2117418)

  • 1. Oral ofloxacin therapy of Pseudomonas aeruginosa sepsis in mice after irradiation.
    Brook I; Ledney GD
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1387-9. PubMed ID: 2117418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short and long courses of ofloxacin therapy of Klebsiella pneumoniae sepsis following irradiation.
    Brook I; Ledney GD
    Radiat Res; 1992 Apr; 130(1):61-4. PubMed ID: 1561319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone therapy of Klebsiella pneumoniae sepsis following irradiation: comparison of pefloxacin, ciprofloxacin, and ofloxacin.
    Brook I; Elliott TB; Ledney GD
    Radiat Res; 1990 May; 122(2):215-7. PubMed ID: 2186431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral aminoglycoside and ofloxacin therapy in the prevention of gram-negative sepsis after irradiation.
    Brook I; Ledney GD
    J Infect Dis; 1991 Nov; 164(5):917-21. PubMed ID: 1940469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo oral efficacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia.
    Yagel SK; Barrett JF; Amaratunga DJ; Frosco MB
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2894-7. PubMed ID: 9124863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone therapy in the prevention of mortality after irradiation.
    Brook I; Elliott TB
    Radiat Res; 1991 Oct; 128(1):100-3. PubMed ID: 1924719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic efficacy of ofloxacin against experimental pneumonia with Pseudomonas aeruginosa in guinea pigs.
    Otani T; Nakajima R; Hashimoto S; Iigo Y; Ishida Y; Une T; Osada Y
    Arzneimittelforschung; 1989 Jun; 39(6):694-7. PubMed ID: 2775337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice.
    Pan CY; Chao TT; Chen JC; Chen JY; Liu WC; Lin CH; Kuo CM
    Int Immunopharmacol; 2007 May; 7(5):687-700. PubMed ID: 17386416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of infection with Streptococcus bovis and Aspergillus sp. in irradiated mice after glycopeptide therapy.
    Brook I; Tom SP; Ledney GD
    J Antimicrob Chemother; 1993 Nov; 32(5):705-13. PubMed ID: 8125835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel in vitro pharmacodynamic model simulating ofloxacin pharmacokinetics in the treatment of Pseudomonas aeruginosa biofilm-associated infections.
    Noreddin AM; Elkhatib WF
    J Infect Public Health; 2009; 2(3):120-8. PubMed ID: 20701871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of ofloxacin in acute exacerbations of chronic respiratory disease associated with Pseudomonas aeruginosa.
    Meek JC; Maesen FP; Davies BI
    J Antimicrob Chemother; 1989 Sep; 24(3):447-53. PubMed ID: 2808196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ofloxacin and penicillin G combination therapy in prevention of bacterial translocation and animal mortality after irradiation.
    Brook I; Ledney GD
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1685-7. PubMed ID: 1929342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolone therapy in the prevention of endogenous and exogenous infection after irradiation.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Apr; 33(4):777-84. PubMed ID: 8056696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of amikacin, ofloxacin, pefloxacin, ciprofloxacin, enoxacin and fleroxacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
    Papadakis JA; Samonis G; Maraki S; Boutsikakis J; Petrocheilou V; Saroglou G
    Chemotherapy; 2000; 46(2):116-21. PubMed ID: 10671762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ofloxacin for infections caused by bacteria resistant to oral antimicrobial agents.
    Eron LJ; Gentry LO
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):435-9. PubMed ID: 1643820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.
    Kemmerich B; Small GJ; Pennington JE
    Antimicrob Agents Chemother; 1986 Mar; 29(3):395-9. PubMed ID: 2940970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-2 enhances survival in experimental sepsis induced by multidrug-resistant Pseudomonas aeruginosa.
    Tzepi IM; Giamarellos-Bourboulis EJ; Carrer DP; Tsaganos T; Claus RA; Vaki I; Pelekanou A; Kotsaki A; Tziortzioti V; Topouzis S; Bauer M; Papapetropoulos A
    J Pharmacol Exp Ther; 2012 Nov; 343(2):278-87. PubMed ID: 22859861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice].
    Padeĭskaia EN; Mnatsakanian VE
    Antibiot Khimioter; 1991 Jul; 36(7):25-8. PubMed ID: 1953184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced bacterial uptake and bactericidal properties of ofloxacin loaded on bioadhesive hydrogels against Pseudomonas aeruginosa.
    Romero VL; Manzo RH; Alovero FL
    J Chemother; 2010 Oct; 22(5):328-34. PubMed ID: 21123156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.